OFIX
Orthofix Medical Inc.
$9.77
-$0.98(-9.12%)
48
Overall
40
Value
58
Tech
47
Quality
Market Cap
$488.70M
Volume
966.48K
52W Range
$9.50 - $16.99
Target Price
$16.25
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $409.8M | $433.8M | $453.0M | $460.0M | $406.6M | $464.5M | $460.7M | $746.6M | $799.5M | $822.3M | ||
| Total Revenue | $409.8M | $433.8M | $453.0M | $460.0M | $406.6M | $464.5M | $460.7M | $746.6M | $799.5M | $822.3M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-87.9M | $-93.0M | $-96.6M | $100.6M | $101.9M | $114.9M | $123.5M | $260.4M | $253.6M | $256.3M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $321.9M | $340.8M | $356.4M | $359.3M | $304.7M | $349.6M | $337.2M | $486.3M | $545.9M | $566.0M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $286.5M | $300.0M | $326.3M | $309.7M | $311.9M | $322.7M | $357.8M | $610.6M | $606.2M | $620.2M | ||
| Research & Development | $28.8M | $29.7M | $33.2M | $34.6M | $39.1M | $49.6M | $49.1M | $80.2M | $73.6M | $65.8M | ||
| Research Expense | $28.8M | $29.7M | $33.2M | $34.6M | $39.1M | $49.6M | $49.1M | $80.2M | $73.6M | $65.8M | ||
| Selling, General & Administrative | $255.7M | $270.3M | $288.8M | $309.3M | $272.4M | $290.7M | $308.8M | $530.4M | $532.5M | $554.3M | ||
| Selling & Marketing Expenses | $181.3M | $198.4M | $205.5M | $223.7M | $204.4M | $221.3M | $228.8M | $385.7M | -- | -- | ||
| General & Administrative Expenses | $74.4M | $71.9M | $83.3M | $85.6M | $67.9M | $69.4M | $80.0M | $530.4M | $532.5M | $554.3M | ||
| Promotion & Advertising | -- | -- | $-600.0K | $800.0K | $900.0K | $500.0K | $500.0K | -- | -- | -- | ||
| Salaries & Wages | $2.0M | $-12.6M | $4.3M | $-34.2M | $499.0K | $-17.6M | $-3.3M | -- | -- | -- | ||
| Depreciation & Amortization | $-20.8M | $-20.1M | $-18.7M | $24.7M | $30.5M | $29.6M | $29.0M | $53.1M | $60.1M | -- | ||
| Depreciation & Amortization | $-20.8M | $-20.1M | $-18.7M | $24.7M | $30.5M | $29.6M | $29.0M | -- | -- | -- | ||
| Amortization | $-1.8M | $-1.8M | $-2.7M | $72.1M | $85.8M | $73.4M | $72.6M | $195.9M | $195.9M | -- | ||
| Other Operating Expenses | $-300.9M | $-300.0M | $-326.3M | $-309.0K | $-568.0K | $-45.0K | $-46.0K | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $35.4M | $40.8M | $30.1M | $-18.8M | $-6.3M | $-8.3M | $-13.3M | $-139.1M | $-84.6M | $-81.4M | ||
| EBITDA | $41.4M | $57.4M | $41.8M | $750.0K | $36.4M | $21.4M | $15.7M | $-87.0M | $-94.2M | $-73.3M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | $122.0K | $2.5M | $1.8M | $1.3M | $8.6M | $29.6M | $17.5M | ||
| Net Non-Operating Interest Income/Expense | -- | -- | -- | $-122.0K | $-2.5M | $-1.8M | $-1.3M | $-8.6M | $-29.6M | $-17.5M | ||
| Gain on Sale of Securities | $2.7M | $5.6M | -- | -- | -- | -- | $187.0K | $1.8M | $5.1M | $-48.0K | ||
| Other Income/Expense | $79.0K | $-1.6M | $6.4M | $8.1M | $-8.4M | $3.3M | $4.3M | $938.0K | $9.6M | $-8.1M | ||
| Other Special Charges | $-2.8M | $-4.0M | $-6.4M | $-8.1M | $8.4M | $-3.3M | $-3.1M | $-938.0K | $-9.6M | $8.1M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $-3.0M | -- | $-500.0K | -- | -- | -- | $-12.0M | $-36.6M | $-14.5M | $-6.1M | ||
| Special Income Charges | $-14.4M | $5.6M | $500.0K | -- | -- | $-11.8M | $11.2M | $22.1M | $-1.3M | $-27.7M | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | $11.8M | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $19.0M | $35.6M | $22.1M | $-27.7M | $2.1M | $-11.7M | $-16.4M | $-140.0M | $-94.2M | $-73.3M | ||
| Pre-Tax Income | $19.0M | $36.4M | $22.9M | $-27.0M | $-368.0K | $-13.5M | $-17.7M | $-148.7M | $-123.9M | $-90.8M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $15.5M | $29.1M | $9.1M | $1.4M | $-2.9M | $24.9M | $2.0M | $2.7M | $2.1M | $1.4M | ||
| NET INCOME | ||||||||||||
| Net Income | $5.8M | $11.8M | $13.8M | $-28.5M | $2.5M | $-38.4M | $-19.7M | $-151.4M | $-126.0M | $-92.2M | ||
| Net Income (Continuing Operations) | $5.8M | $11.8M | $13.8M | $-28.5M | $2.5M | $-38.4M | $-19.7M | $-151.4M | $-126.0M | $-92.2M | ||
| Net Income (Discontinued Operations) | $5.8M | $11.8M | $13.8M | $-28.5M | $2.5M | $-38.4M | $-19.7M | $-151.4M | $-126.0M | $-92.2M | ||
| Net Income (Common Stockholders) | $5.8M | $11.8M | $13.8M | $40.0M | $2.5M | $-38.4M | $-19.7M | $-151.4M | $-126.0M | $-92.2M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-62.2M | ||
| TOTALS | ||||||||||||
| Total Expenses | $198.6M | $206.9M | $229.7M | $410.3M | $413.8M | $437.6M | $481.4M | $871.0M | $859.8M | $876.5M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $18.1M | $18.1M | $18.5M | $18.9M | $19.3M | $19.7M | $20.1M | $36.7M | $38.1M | $39.6M | ||
| Average Shares Outstanding (Diluted) | $18.5M | $18.5M | $18.9M | $18.9M | $19.4M | $19.7M | $20.1M | $36.7M | $38.1M | $39.6M | ||
| Shares Outstanding | $17.9M | $18.4M | $19.1M | $19.2M | $19.5M | $19.9M | $36.5M | $37.4M | $39.0M | $40.1M | ||
| Basic EPS | $0.17 | $0.34 | $0.73 | $-1.51 | $0.13 | $-1.95 | $-0.98 | $-4.12 | $-3.3 | $-2.33 | ||
| Basic EPS (Continuing Operations) | $0.19 | $0.40 | $0.73 | $-1.51 | $0.13 | $-1.95 | $-0.98 | $-4.12 | $-3.3 | $-2.33 | ||
| Diluted EPS | $0.17 | $0.34 | $0.72 | $-1.51 | $0.13 | $-1.95 | $-0.98 | $-4.12 | $-3.3 | $-2.33 | ||
| Diluted EPS (Continuing Operations) | $0.19 | $0.39 | $0.72 | $-1.51 | $0.13 | $-1.95 | $-0.98 | $-4.12 | $-3.3 | $-2.33 | ||
| OTHER METRICS | ||||||||||||
| Acquired In Process Rn D | -- | $5.6M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Acquired In Process Rn D Income | -- | $5.6M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Basic Discontinuous Operations | $-0.02 | $-0.06 | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Diluted Discontinuous Operations | $-0.02 | $-0.05 | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Gains Loss On Disposal Of Discontinued Operations | $-441.0K | $-1.1M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Interest Expense Operating | -- | $-800.0K | $-800.0K | $-800.0K | $-1.9M | $-1.5M | $-1.4M | -- | -- | -- | ||
| Net Income Discontinuous Operations | $-441.0K | $-1.1M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Net Operating Interest Income Expense | $763.0K | $-416.0K | $-828.0K | -- | -- | -- | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | $14.4M | -- | -- | -- | -- | -- | $803.0K | $14.5M | $15.8M | $33.8M | ||
| Other Gand A | $74.4M | $71.9M | $83.3M | $85.6M | $67.9M | $69.4M | $80.0M | $530.4M | $532.5M | $554.3M | ||
| Other Impairment Of Capital Assets | -- | -- | $4.7M | -- | -- | -- | -- | -- | -- | -- | ||
| Other Write Off | -- | -- | -- | -- | $714.0K | $126.0K | $450.0K | -- | -- | -- | ||
| Rent And Landing Fees | $74.4M | $71.9M | $83.3M | -- | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $181.3M | $198.4M | $205.5M | -- | -- | -- | -- | -- | -- | -- | ||
| Write Down | -- | $-5.6M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Restruct | $-3.0M | -- | $-500.0K | -- | -- | -- | $-12.0M | $-36.6M | $-14.5M | $-6.1M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OFIX | $9.77 | -9.1% | 966.48K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |